Medindia

X

Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union

Friday, December 18, 2009 Corporate News J E 4
Advertisement

CONTACT:

Amgen, Zug, Switzerland

Marie Fay: +41 (41) 3690 339 (media, osteoporosis)

Sabeena Ahmad: +41 (41) 3692 530 (media, oncology)

Amgen, Thousand Oaks

Kerry Beth Daly: (805) 447-3020 (media, osteoporosis)

Christine Regan: (805) 447-5476 (media, oncology)

John Shutter: (805) 447-1060 (investors)

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Æterna Zentaris Announces Termination of Agreement...
S
Patheon reports fourth quarter and full year fisca...